117 related articles for article (PubMed ID: 34520770)
81. Fatty acid synthase inhibition by amentoflavone suppresses HER2/neu (erbB2) oncogene in SKBR3 human breast cancer cells.
Lee JS; Sul JY; Park JB; Lee MS; Cha EY; Song IS; Kim JR; Chang ES
Phytother Res; 2013 May; 27(5):713-20. PubMed ID: 22767439
[TBL] [Abstract][Full Text] [Related]
82. 3,3'-diindolylmethane and paclitaxel act synergistically to promote apoptosis in HER2/Neu human breast cancer cells.
McGuire KP; Ngoubilly N; Neavyn M; Lanza-Jacoby S
J Surg Res; 2006 May; 132(2):208-13. PubMed ID: 16580691
[TBL] [Abstract][Full Text] [Related]
83. Nitric Oxide-Releasing Aspirin Suppresses NF-κB Signaling in Estrogen Receptor Negative Breast Cancer Cells in Vitro and in Vivo.
Nath N; Chattopadhyay M; Rodes DB; Nazarenko A; Kodela R; Kashfi K
Molecules; 2015 Jul; 20(7):12481-99. PubMed ID: 26184135
[TBL] [Abstract][Full Text] [Related]
84. Incorporation of lapatinib into human serum albumin nanoparticles with enhanced anti-tumor effects in HER2-positive breast cancer.
Wan X; Zheng X; Pang X; Zhang Z; Zhang Q
Colloids Surf B Biointerfaces; 2015 Dec; 136():817-27. PubMed ID: 26539808
[TBL] [Abstract][Full Text] [Related]
85. STAT3-survivin signaling mediates a poor response to radiotherapy in HER2-positive breast cancers.
Kim JS; Kim HA; Seong MK; Seol H; Oh JS; Kim EK; Chang JW; Hwang SG; Noh WC
Oncotarget; 2016 Feb; 7(6):7055-65. PubMed ID: 26755645
[TBL] [Abstract][Full Text] [Related]
86. Sphingosine 1-phosphate receptor 4 uses HER2 (ERBB2) to regulate extracellular signal regulated kinase-1/2 in MDA-MB-453 breast cancer cells.
Long JS; Fujiwara Y; Edwards J; Tannahill CL; Tigyi G; Pyne S; Pyne NJ
J Biol Chem; 2010 Nov; 285(46):35957-66. PubMed ID: 20837468
[TBL] [Abstract][Full Text] [Related]
87. [HER2 promotes cell migration via inhibiting the expression of E-cadherin in human mammary epithelial cells].
Liang S; Jiang Z; Liu H; Yang X
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2017 Jun; 33(6):795-799. PubMed ID: 28615103
[TBL] [Abstract][Full Text] [Related]
88. HER2 induces cell scattering and invasion through ∆Np63α and E-cadherin.
Liang S; Tang X; Ye T; Xiang W
Biochem Cell Biol; 2022 Oct; 100(5):403-412. PubMed ID: 36073720
[TBL] [Abstract][Full Text] [Related]
89. Anti-EMT properties of CoQ0 attributed to PI3K/AKT/NFKB/MMP-9 signaling pathway through ROS-mediated apoptosis.
Yang HL; Thiyagarajan V; Shen PC; Mathew DC; Lin KY; Liao JW; Hseu YC
J Exp Clin Cancer Res; 2019 May; 38(1):186. PubMed ID: 31068208
[TBL] [Abstract][Full Text] [Related]
90. The fibroblast growth factor-inducible 14 receptor is highly expressed in HER2-positive breast tumors and regulates breast cancer cell invasive capacity.
Willis AL; Tran NL; Chatigny JM; Charlton N; Vu H; Brown SA; Black MA; McDonough WS; Fortin SP; Niska JR; Winkles JA; Cunliffe HE
Mol Cancer Res; 2008 May; 6(5):725-34. PubMed ID: 18505918
[TBL] [Abstract][Full Text] [Related]
91. The differential expression of EphB2 and EphB4 receptor kinases in normal bladder and in transitional cell carcinoma of the bladder.
Li X; Choi WW; Yan R; Yu H; Krasnoperov V; Kumar SR; Schuckman A; Klumpp DJ; Pan CX; Quinn D; Gill IS; Gill PS; Liu R
PLoS One; 2014; 9(8):e105326. PubMed ID: 25148033
[TBL] [Abstract][Full Text] [Related]
92. Pharmacological blockade of fatty acid synthase (FASN) reverses acquired autoresistance to trastuzumab (Herceptin by transcriptionally inhibiting 'HER2 super-expression' occurring in high-dose trastuzumab-conditioned SKBR3/Tzb100 breast cancer cells.
Vazquez-Martin A; Colomer R; Brunet J; Menendez JA
Int J Oncol; 2007 Oct; 31(4):769-76. PubMed ID: 17786307
[TBL] [Abstract][Full Text] [Related]
93. A COX-2 inhibitor nimesulide analog selectively induces apoptosis in Her2 overexpressing breast cancer cells via cytochrome c dependent mechanisms.
Chen B; Su B; Chen S
Biochem Pharmacol; 2009 Jun; 77(12):1787-94. PubMed ID: 19428334
[TBL] [Abstract][Full Text] [Related]
94. HER-targeted tyrosine kinase inhibitors enhance response to trastuzumab and pertuzumab in HER2-positive breast cancer.
Canonici A; Ivers L; Conlon NT; Pedersen K; Gaynor N; Browne BC; O'Brien NA; Gullo G; Collins DM; O'Donovan N; Crown J
Invest New Drugs; 2019 Jun; 37(3):441-451. PubMed ID: 30062574
[TBL] [Abstract][Full Text] [Related]
95. The EphB6 receptor cooperates with c-Cbl to regulate the behavior of breast cancer cells.
Truitt L; Freywald T; DeCoteau J; Sharfe N; Freywald A
Cancer Res; 2010 Feb; 70(3):1141-53. PubMed ID: 20086179
[TBL] [Abstract][Full Text] [Related]
96. Anti-tumor effects of retinoids combined with trastuzumab or tamoxifen in breast cancer cells: induction of apoptosis by retinoid/trastuzumab combinations.
Koay DC; Zerillo C; Narayan M; Harris LN; DiGiovanna MP
Breast Cancer Res; 2010; 12(4):R62. PubMed ID: 20696059
[TBL] [Abstract][Full Text] [Related]
97. Mitochondrial HER2 stimulates respiration and promotes tumorigenicity.
Novotna E; Milosevic M; Prukova D; Magalhaes-Novais S; Dvorakova S; Dmytruk K; Gemperle J; Zudova D; Nickl T; Vrbacky M; Rosel D; Filimonenko V; Prochazka J; Brabek J; Neuzil J; Rohlenova K; Rohlena J
Eur J Clin Invest; 2024 Jun; 54(6):e14174. PubMed ID: 38291340
[TBL] [Abstract][Full Text] [Related]
98. Discovery of Pyrimidine- and Coumarin-Linked Hybrid Molecules as Inducers of JNK Phosphorylation through ROS Generation in Breast Cancer Cells.
Kim NY; Vishwanath D; Xi Z; Nagaraja O; Swamynayaka A; Kumar Harish K; Basappa S; Madegowda M; Pandey V; Sethi G; Lobie PE; Ahn KS; Basappa B
Molecules; 2023 Apr; 28(8):. PubMed ID: 37110684
[TBL] [Abstract][Full Text] [Related]
99. Correction: Janus-faced EPHB4-associated disorders: novel pathogenic variants and unreported intrafamilial overlapping phenotypes.
Martin-Almedina S; Ogmen K; Sackey E; Grigoriadis D; Karapouliou C; Nadarajah N; Ebbing C; Lord J; Mellis R; Kortuem F; Dinulos MB; Polun C; Bale S; Atton G; Robinson A; Reigstad H; Houge G; von der Wense A; Becker WH; Jeffery S; Mortimer PS; Gordon K; Josephs KS; Robart S; Kilby MD; Vallee S; Gorski JL; Hempel M; Berland S; Mansour S; Ostergaard P
Genet Med; 2021 Jul; 23(7):1376-1377. PubMed ID: 34040196
[No Abstract] [Full Text] [Related]
100. Mechanisms of Cell Adhesion Molecules in Endocrine-Related Cancers: A Concise Outlook.
Ruan Y; Chen L; Xie D; Luo T; Xu Y; Ye T; Chen X; Feng X; Wu X
Front Endocrinol (Lausanne); 2022; 13():865436. PubMed ID: 35464064
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
